Guido Lattuada
Research Subjects
Guido Lattuada has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Gianluca Perseghin
Department of Medicine and Surgery, University of Milano Bicocca, 20126 Milan, Italy
5 shared publications - Emanuele Muraca
Department of Medicine and Rehabilitation, Policlinico di Monza, Monza, Italy
4 shared publications - Stefano Ciardullo
Department of Medicine and Surgery, University of Milano Bicocca, 20126 Milan, Italy
4 shared publications Giuseppina Manzoni
Department of Medicine and Rehabilitation; Policlinico di Monza, 20900 Monza, Italy
3 shared publicationsAlice Oltolini
Department of Medicine and Rehabilitation; Policlinico di Monza, 20900 Monza, Italy
2 shared publicationsFrancesca Zerbini
Department of Medicine and Rehabilitation; Policlinico di Monza, 20900 Monza, Italy
2 shared publications
Latest Publications
- 11 March 2021
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 106 (8) , e3087-e3097
Metabolic and Psychological Features are Associated with Weight Loss 12 Months After Sleeve Gastrectomy
Context: Laparoscopic sleeve gastrectomy (LSG) is a recognized effective procedure of bariatric surgery, but a poor response in weight loss may still represent a clinical problem. To date there are no validated predictors useful to better perform patient selection. Objective: To establish the association of baseline anthropometric, metabolic, and psychologic features with the percent total weight loss (%TWL) and percent excess weight loss (%EWL) 12 months after surgery. Design: Retrospective longitudinal analysis of a set of data about obese patients attending the outpatient service of a single obesity center from June 2016 to June 2019. Patients: A total of 106 obese patients underwent LSG with presurgery evaluation and follow-up at 12 months after surgery. Main outcome: Weight loss 12 months after LSG. Results: Patients who achieved a %TWL higher than the observed median (≥34%) were younger, with a lower fasting plasma glucose and glycated hemoglobin, with a lower prevalence of hypertension and with a lower score in the impulsiveness scale, compared with patients with a %TWL < 34%. Similar findings were found when %EWL was considered. Multivariable stepwise regression analysis showed that younger age, lower impulsiveness, higher-than-normal urinary free cortisol, and lower HbA1c were associated with higher %TWL, explaining about 31.5% of the weight loss. Conclusion: Metabolic and psychologic features at baseline were independently associated with weight loss and explained a non-negligible effect on the response to LSG. These data suggest that careful metabolic and psychologic profiling could help in sharper indications and personalized pre- and postsurgical follow-up protocols in candidates for LSG.
- 11 March 2021
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 106 (8) , e3087-e3097
Metabolic and Psychological Features are Associated with Weight Loss 12 Months After Sleeve Gastrectomy
Context: Laparoscopic sleeve gastrectomy (LSG) is a recognized effective procedure of bariatric surgery, but a poor response in weight loss may still represent a clinical problem. To date there are no validated predictors useful to better perform patient selection. Objective: To establish the association of baseline anthropometric, metabolic, and psychologic features with the percent total weight loss (%TWL) and percent excess weight loss (%EWL) 12 months after surgery. Design: Retrospective longitudinal analysis of a set of data about obese patients attending the outpatient service of a single obesity center from June 2016 to June 2019. Patients: A total of 106 obese patients underwent LSG with presurgery evaluation and follow-up at 12 months after surgery. Main outcome: Weight loss 12 months after LSG. Results: Patients who achieved a %TWL higher than the observed median (≥34%) were younger, with a lower fasting plasma glucose and glycated hemoglobin, with a lower prevalence of hypertension and with a lower score in the impulsiveness scale, compared with patients with a %TWL < 34%. Similar findings were found when %EWL was considered. Multivariable stepwise regression analysis showed that younger age, lower impulsiveness, higher-than-normal urinary free cortisol, and lower HbA1c were associated with higher %TWL, explaining about 31.5% of the weight loss. Conclusion: Metabolic and psychologic features at baseline were independently associated with weight loss and explained a non-negligible effect on the response to LSG. These data suggest that careful metabolic and psychologic profiling could help in sharper indications and personalized pre- and postsurgical follow-up protocols in candidates for LSG.
- Open Access
- 10 August 2020
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 44 (4) , 843-850
Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy
Purpose: The purpose of this study was to evaluate the impact of pre-existing diabetes on in-hospital mortality in patients admitted for Coronavirus Disease 2019 (COVID-19).Methods: This is a single center, retrospective study conducted at Policlinico di Monza hospital, located in the Lombardy region, Northern Italy. We reviewed medical records of 373 consecutive adult patients who were hospitalized with COVID-19 between February 22 and May 15, 2020. Data were collected on diabetes status, comorbid conditions and laboratory findings. Multivariable logistic regression was performed to evaluate the effect of diabetes on in-hospital mortality after adjustment for potential confounding variables.Results: Mean age of the patients was 72 ± 14 years (range 17–98), 244 (65.4%) were male and 69 (18.5%) had diabetes. The most common comorbid conditions were hypertension (237 [64.8%]), cardiovascular disease (140 [37.7%]) and malignant neoplasms (50 [13.6%]). In-hospital death occurred in 142 (38.0%) patients. In the multivariable model older age (Relative Risk [RR] 1.06 [1.04–1. 09] per year), diabetes (RR 1.56 [1.05–2.02]), chronic obstructive pulmonary disease (RR 1.82 [1.13–2.35]), higher values of lactic dehydrogenase and C-reactive protein were independently associated with in-hospital mortality.Conclusion: In this retrospective single-center study, diabetes was independently associated with a higher in-hospital mortality. More intensive surveillance of patients with this condition is to be warranted.
- 10 August 2020
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 44 (4) , 843-850
Open AccessImpact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy
Purpose: The purpose of this study was to evaluate the impact of pre-existing diabetes on in-hospital mortality in patients admitted for Coronavirus Disease 2019 (COVID-19).Methods: This is a single center, retrospective study conducted at Policlinico di Monza hospital, located in the Lombardy region, Northern Italy. We reviewed medical records of 373 consecutive adult patients who were hospitalized with COVID-19 between February 22 and May 15, 2020. Data were collected on diabetes status, comorbid conditions and laboratory findings. Multivariable logistic regression was performed to evaluate the effect of diabetes on in-hospital mortality after adjustment for potential confounding variables.Results: Mean age of the patients was 72 ± 14 years (range 17–98), 244 (65.4%) were male and 69 (18.5%) had diabetes. The most common comorbid conditions were hypertension (237 [64.8%]), cardiovascular disease (140 [37.7%]) and malignant neoplasms (50 [13.6%]). In-hospital death occurred in 142 (38.0%) patients. In the multivariable model older age (Relative Risk [RR] 1.06 [1.04–1. 09] per year), diabetes (RR 1.56 [1.05–2.02]), chronic obstructive pulmonary disease (RR 1.82 [1.13–2.35]), higher values of lactic dehydrogenase and C-reactive protein were independently associated with in-hospital mortality.Conclusion: In this retrospective single-center study, diabetes was independently associated with a higher in-hospital mortality. More intensive surveillance of patients with this condition is to be warranted.
- Open Access
- 19 June 2020
- Published by Springer Nature in Research Square
Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy
Purpose. The purpose of this study was to evaluate the impact of pre-existing diabetes on in-hospital mortality in patients admitted for Coronavirus Disease 2019 (COVID-19).Methods. This is a single center, retrospective study conducted at Policlinico di Monza hospital, located in the Lombardy region, Northern Italy. We reviewed medical records of 373 consecutive adult patients who were hospitalized with COVID-19 between February 22 and May 15, 2020. Data were collected on diabetes status, comorbid conditions and laboratory findings. Multivariable logistic regression was performed to evaluate the effect of diabetes on in-hospital mortality after adjustment for potential confounding variables.Results. Mean age of the patients was 72 ± 14 years (range 17-98), 244 (65.4%) were male and 69 (18.5%) had diabetes. The most common comorbid conditions were hypertension (237 [64.8%]), cardiovascular disease (140 [37.7%]) and malignant neoplasms (50 [13.6%]). In-hospital death occurred in 142 (38.0%) patients. In the multivariable model older age (Odds Ratio [OR] 1.07 [1.04-1.10] per year), diabetes (OR 2.2 [1.10-4.73]), chronic obstructive pulmonary disease (OR 3.30 [1.22-8.90]), higher values of lactic dehydrogenase and C-reactive protein were independently associated with in-hospital mortality.Conclusion. In this retrospective single-center study, diabetes was independently associated with a higher in-hospital mortality. More intensive surveillance of patients with this condition is to be warranted.
- 19 June 2020
- Published by Springer Nature in Research Square
Open AccessImpact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy
Purpose. The purpose of this study was to evaluate the impact of pre-existing diabetes on in-hospital mortality in patients admitted for Coronavirus Disease 2019 (COVID-19).Methods. This is a single center, retrospective study conducted at Policlinico di Monza hospital, located in the Lombardy region, Northern Italy. We reviewed medical records of 373 consecutive adult patients who were hospitalized with COVID-19 between February 22 and May 15, 2020. Data were collected on diabetes status, comorbid conditions and laboratory findings. Multivariable logistic regression was performed to evaluate the effect of diabetes on in-hospital mortality after adjustment for potential confounding variables.Results. Mean age of the patients was 72 ± 14 years (range 17-98), 244 (65.4%) were male and 69 (18.5%) had diabetes. The most common comorbid conditions were hypertension (237 [64.8%]), cardiovascular disease (140 [37.7%]) and malignant neoplasms (50 [13.6%]). In-hospital death occurred in 142 (38.0%) patients. In the multivariable model older age (Odds Ratio [OR] 1.07 [1.04-1.10] per year), diabetes (OR 2.2 [1.10-4.73]), chronic obstructive pulmonary disease (OR 3.30 [1.22-8.90]), higher values of lactic dehydrogenase and C-reactive protein were independently associated with in-hospital mortality.Conclusion. In this retrospective single-center study, diabetes was independently associated with a higher in-hospital mortality. More intensive surveillance of patients with this condition is to be warranted.
- Open Access
- 1 February 2020
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 13, 489-497
Resting Whole Body Energy Metabolism in Class 3 Obesity; from Preserved Insulin Sensitivity to Overt Type 2 Diabetes
Context: Insulin resistance and diabetes may influence separately or in combination whole body energy metabolism. Objective: To assess the impact of insulin resistance and/or overt type 2 diabetes on resting energy expenditure (REE) in class 3 obese individuals. Design and Setting: Retrospective, cross-sectional analysis of a set of data about individuals attending the outpatients service of a single center of bariatric surgery between January 2015 and December 2017. Patients: We screened 382 patients in which abnormal thyroid function was excluded, and segregated them in three groups of subjects: patients with type 2 diabetes (T2DM; n=70), non-diabetic insulin-resistant patients with HOMA-IR ≥ 3 (n=236), non-diabetic insulin-sensitive patients with HOMA-IR < 3 (n=75). Main Outcome Measure: Resting energy expenditure (REE), body composition and insulin resistance assessed using indirect calorimetry, bioimpedance and HOMA-IR. Results: Non-diabetic insulin-sensitive patients resulted to be younger, with lower BMI and higher prevalence of female subjects; meanwhile, non-diabetic but insulin-resistant patients and T2DM patients were not different in terms of anthropometric parameters. REE was higher in T2DM than in non-diabetic insulin-resistant and insulin-sensitive individuals when expressed as percent of the predicted REE (based on Harris Benedict equation) (p< 0.0001) or when adjusted for kg of free fat mass (p< 0.0001) and was found to be higher also in insulin-resistant vs insulin-sensitive patients (p< 0.001). The respiratory quotient was different between groups (0.87± 0.11, 0.86± 0.12 and 0.91± 0.14 in T2DM, insulin-resistant and insulin-sensitive patients, respectively; p< 0.03). Regression analysis confirmed that HOMA-IR was independently associated with the REE (R2=0.110, p< 0.001). Conclusion: Class 3 obese patients with normal insulin sensitivity are characterized by reduced fasting REE in comparison to insulin-resistant obese patients and obese patients with short duration of diabetes supporting the hypothesis that down-regulation of nutrients’ oxidative disposal may represent an adaptation of energy metabolism in obese individuals with preserved insulin sensitivity.
- 1 February 2020
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 13, 489-497
Open AccessResting Whole Body Energy Metabolism in Class 3 Obesity; from Preserved Insulin Sensitivity to Overt Type 2 Diabetes
Context: Insulin resistance and diabetes may influence separately or in combination whole body energy metabolism. Objective: To assess the impact of insulin resistance and/or overt type 2 diabetes on resting energy expenditure (REE) in class 3 obese individuals. Design and Setting: Retrospective, cross-sectional analysis of a set of data about individuals attending the outpatients service of a single center of bariatric surgery between January 2015 and December 2017. Patients: We screened 382 patients in which abnormal thyroid function was excluded, and segregated them in three groups of subjects: patients with type 2 diabetes (T2DM; n=70), non-diabetic insulin-resistant patients with HOMA-IR ≥ 3 (n=236), non-diabetic insulin-sensitive patients with HOMA-IR < 3 (n=75). Main Outcome Measure: Resting energy expenditure (REE), body composition and insulin resistance assessed using indirect calorimetry, bioimpedance and HOMA-IR. Results: Non-diabetic insulin-sensitive patients resulted to be younger, with lower BMI and higher prevalence of female subjects; meanwhile, non-diabetic but insulin-resistant patients and T2DM patients were not different in terms of anthropometric parameters. REE was higher in T2DM than in non-diabetic insulin-resistant and insulin-sensitive individuals when expressed as percent of the predicted REE (based on Harris Benedict equation) (p< 0.0001) or when adjusted for kg of free fat mass (p< 0.0001) and was found to be higher also in insulin-resistant vs insulin-sensitive patients (p< 0.001). The respiratory quotient was different between groups (0.87± 0.11, 0.86± 0.12 and 0.91± 0.14 in T2DM, insulin-resistant and insulin-sensitive patients, respectively; p< 0.03). Regression analysis confirmed that HOMA-IR was independently associated with the REE (R2=0.110, p< 0.001). Conclusion: Class 3 obese patients with normal insulin sensitivity are characterized by reduced fasting REE in comparison to insulin-resistant obese patients and obese patients with short duration of diabetes supporting the hypothesis that down-regulation of nutrients’ oxidative disposal may represent an adaptation of energy metabolism in obese individuals with preserved insulin sensitivity.
- 1 September 2017
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 35 (Supplement) , e219-e220
[PP.16.07] CVD RISK IS INDEPENDENTLY ASSOCIATED WITH VISIT-TO-VISIT VARIABILITY OF SYSTOLIC BLOOD PRESSURE (BP) IN PATIENTS WITH TYPE 2 DIABETES
Objective: Recent evidence suggest that CVD risk is related also on the consistency of BP control between on-treatment visits. Visit-to-visit variability of systolic BP is a biomarker of arterial stiffness, autonomic dysfunction, endothelial damage and systemic inflammation but it may also reflect poor patients’ adherence to the pharmacologic therapy. Design and method: We analyzed the relationships between micro-and macro-vascular complications of diabetes in 818 patients attending at least four times our secondary care diabetes clinic between 2013–15 with the standard deviation of the visit-to-visit variability of sitting systolic BP. We segregated these patients in tertiles of the standard deviation of visit-to-visit variability. Results: Patients with the high visit-to-visit variability were older (p < 0.0001), with higher waist circumference (p < 0.022), higher systolic (136 ± 17, 138 ± 15 and 142 ± 14 mm Hg; p < 0.0001), but not diastolic (79 ± 9, 78 ± 10 and 78 ± 9 mm Hg; p = 0.56) blood pressure and heart rate (78 ± 12, 78 ± 10 and 77 ± 9; p = 0.32). Glycemic control was not different between tertiles, meanwhile estimated GFR was lower in the tertile with high visit-to-visit variability of BP (p < 0.0001). Diabetic retinopathy (19%, 17% and 26%; p < 0.05) but not microalbuminuria (32%, 36% and 37%; p < 0.48) was more frequent in those with high visit-to-visit variability of BP. Established CVD was more prevalent in patients with high variability (35%, 50%, 72%; p < 0.0001). Treatments with statin (61%, 76% and 74%; p < 00001) and anti-hypertensive drugs (ACE-inhibitors and Ca antagonists in particular) were also more frequent in patients with high variability. When multivariate analysis of regression was performed with the 10 year UKPDS Risk Engine used as dependent variable, visit-to-visit variability of BP was independently associated with the risks of coronary heart disease, fatal CHD, and more tightly with the risks of stroke and fatal stroke also when adjusted for max systolic blood pressure and drug therapy. Conclusions: The results of this analysis support the hypothesis that in patient with type 2 diabetes a lack of stable control of ambulatory BP is related to established CVD and increased risk of CVD events.
- 1 September 2017
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 35 (Supplement) , e219-e220
[PP.16.07] CVD RISK IS INDEPENDENTLY ASSOCIATED WITH VISIT-TO-VISIT VARIABILITY OF SYSTOLIC BLOOD PRESSURE (BP) IN PATIENTS WITH TYPE 2 DIABETES
Objective: Recent evidence suggest that CVD risk is related also on the consistency of BP control between on-treatment visits. Visit-to-visit variability of systolic BP is a biomarker of arterial stiffness, autonomic dysfunction, endothelial damage and systemic inflammation but it may also reflect poor patients’ adherence to the pharmacologic therapy. Design and method: We analyzed the relationships between micro-and macro-vascular complications of diabetes in 818 patients attending at least four times our secondary care diabetes clinic between 2013–15 with the standard deviation of the visit-to-visit variability of sitting systolic BP. We segregated these patients in tertiles of the standard deviation of visit-to-visit variability. Results: Patients with the high visit-to-visit variability were older (p < 0.0001), with higher waist circumference (p < 0.022), higher systolic (136 ± 17, 138 ± 15 and 142 ± 14 mm Hg; p < 0.0001), but not diastolic (79 ± 9, 78 ± 10 and 78 ± 9 mm Hg; p = 0.56) blood pressure and heart rate (78 ± 12, 78 ± 10 and 77 ± 9; p = 0.32). Glycemic control was not different between tertiles, meanwhile estimated GFR was lower in the tertile with high visit-to-visit variability of BP (p < 0.0001). Diabetic retinopathy (19%, 17% and 26%; p < 0.05) but not microalbuminuria (32%, 36% and 37%; p < 0.48) was more frequent in those with high visit-to-visit variability of BP. Established CVD was more prevalent in patients with high variability (35%, 50%, 72%; p < 0.0001). Treatments with statin (61%, 76% and 74%; p < 00001) and anti-hypertensive drugs (ACE-inhibitors and Ca antagonists in particular) were also more frequent in patients with high variability. When multivariate analysis of regression was performed with the 10 year UKPDS Risk Engine used as dependent variable, visit-to-visit variability of BP was independently associated with the risks of coronary heart disease, fatal CHD, and more tightly with the risks of stroke and fatal stroke also when adjusted for max systolic blood pressure and drug therapy. Conclusions: The results of this analysis support the hypothesis that in patient with type 2 diabetes a lack of stable control of ambulatory BP is related to established CVD and increased risk of CVD events.